All Stories

  1. Transformative role of artificial intelligence (AI) in pandemic preparedness and mitigation: the COVID-19 experience
  2. Towards safer medication use in older adults: Investigating barriers and facilitators of deprescribing
  3. Does Metformin Improve Thyroid Function? A Short Review
  4. Use of artificial intelligence (AI) in medical postgraduate training
  5. Assessing the Efficacy of the ARMOR Tool–Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk–Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial
  6. Applications of artificial intelligence and machine learning in clinical medicine: What lies ahead?
  7. Introduction to intellectual property rights and drug patents
  8. Assessing the Efficacy of the ARMOR Tool–Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk–Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial (Preprint)
  9. Inception of the Indian Digital Health Mission: Connecting…the…Dots
  10. Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review
  11. Ivermectin in COVID-19 Management: What is the current evidence?
  12. Introduction to Basics of Pharmacology and Toxicology
  13. Antifungal Drugs
  14. Antimycobacterial Drugs
  15. Antiplatelets, Anticoagulants, and Fibrinolytics
  16. Introduction to Basics of Pharmacology and Toxicology
  17. Precision medicine in diabetes— Finally some light at the end of the tunnel?
  18. Association of plasma docetaxel levels with ABCB1 gene polymorphisms and tumour response in locally advanced breast cancer patients of South India on neo‐adjuvant chemotherapy
  19. Effect of long-term acid suppression therapy with proton pump inhibitors or H2 receptor blockers on serum vitamin B12 levels in elderly population
  20. Letter to the Editor
  21. Letter to the Editor: “Association between metformin medication, genetic variation and prostate cancer risk”—genotyping and patient categorizations, do they matter?
  22. Dapagliflozin for heart failure – is it a class effect?
  23. 5G in healthcare: how fast will be the transformation?
  24. Artificial Intelligence during a pandemic: The COVID ‐19 example
  25. Monoclonal antibodies against infectious microbes: so long and too little!
  26. Knowledge, attitude and practice of hypertension among hypertensive patients in a tertiary care teaching hospital
  27. Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India
  28. Evaluation of Pattern of Oral Hypoglycaemic Agents Usage and their Cost among Type-2 Diabetic Patients in a Tertiary Care Teaching Hospital
  29. Pharmacogenetics, Pharmacogenomics, and Personalized Medicine
  30. Study of Treatment Pattern and Treatment Satisfaction with its Impact on Quality of Life among Psoriasis Patients
  31. The Great Pharmacologists and Their Revolutionary Discoveries
  32. Intellectual Property Issues Surrounding Antimicrobial Agents
  33. Introduction to Basics of Pharmacology and Toxicology
  34. Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients
  35. Commentary to “Patients not patents: drug research and development as a public enterprise”
  36. Cetirizine-induced fixed drug eruption
  37. Status of Pharmacogenomics Research in India during the last Five Years
  38. Genetic polymorphisms of multidrug and toxin extrusion proteins (MATE1 and MATE2) in South Indian population
  39. Drug patents and intellectual property rights
  40. Pathophysiological and pharmacological modulation of melatonergic system
  41. Intellectual property rights in drug development and biotechnology.